Drugs / LON002
last change Jun 2017 re-read 3 minutes ago

LON002

Developed for
cancer
Investigated by
LondonPharma Ltd.

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT02390986 Jan 2015 → Jun 2017 cancer LondonPharma Ltd. Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as LON002 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02390986 ↗